NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB). The update note includes information on the Enveric Bioscience’s management commentary, recent developments, outlook, and risks.  The full research report is available here. Highlights from the report include:  EB-003 Elevated to Lead Development Candidate by Enveric Biosciences: Enveric ...